article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has supported the use of artificial intelligence (AI) to deliver benefit for patients, life science companies and society, in response to the EU Artificial Intelligence (AI) Act.

article thumbnail

Transforming pharma R&D with a scientist-centric approach to AI & automation

pharmaphorum

Borrowing from the Computer-Aided Design and Manufacturing (CAD/CAM) approaches in the semiconductor industry, a similar concept, called Computer-Aided Biology (CAB), can be applied to the life sciences. Life sciences are on the cusp of a quantum leap, fuelled in part by the spotlight on digitalisation created by the COVID-19 pandemic.